Research Progress on Osteoporosis in Women of Childbearing Age
1. The Community Health Service Center at Guanshang Street, Guandu District, Kunming 650200, China
2. The Community Health Service Center at Jinma Street, Guandu District, Kunming 650216, China
3. College of the First Clinical, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
| Abstract: | Osteoporosis is a common clinical disease, with osteoporosis in China accounting for about 7% of the total population. As a systemic bone disease, in recent years, there has been an increasing incidence among women of childbearing age, posing a serious threat to women's health. The disease mechanism of osteoporosis is complex, involving factors such as unhealthy lifestyle and hormonal imbalance, with diverse clinical manifestations including pain, spinal deformity, and fractures. This article aims to comprehensively analyze the clinical and mechanistic issues of osteoporosis in women of childbearing age, including a systematic discussion of its epidemiological characteristics, potential risk factors, pathophysiological processes, typical clinical manifestations, and current treatment strategies. Various strategies for the prevention and treatment of osteoporosis are proposed in the article, including exercise therapy, calcium and vitamin D supplementation, traditional Chinese medicine treatments (including drug and non-drug treatments such as acupuncture and massage), surgical treatment, and physical factor therapy. Emphasis is placed on the importance of health education in preventing osteoporosis, advocating for disease prevention through improving lifestyle and dietary habits. The main goal is to provide a solid theoretical basis for the development of more scientifically effective treatment strategies, improve bone mineral density levels in postmenopausal osteoporosis patients, effectively alleviate the pain caused by the disease, significantly reduce the risk of fractures, and enhance the quality of life of women of childbearing age. |
| Keywords: | Osteoporosis; Women of Childbearing Age; Risk Factors |
| DOI: | 10.57237/j.cmf.2024.02.002 |
View:
Downloads:
Received: 23 June 2024
Accepted: 23 July 2024
Published Online: 29 July 2024
Funding
| 1. | 云南省万人计划名医专项人才项目 (2019-35) |
| 2. | 云南省基层名中医工作站建设项目 (2021-01) |
| 3. | 昆明市卫生科研课题立项项目 (2022-14-01-023) |
References
| [1] | 王起山, 赵军英, 魏鑫越, 等. 乳制品对骨质疏松症的预防和干预作用研究进展 [J]. 食品科学, 2023, 44(9): 245-258. |
| [2] | 徐帅, 沈飞. 脑-骨交互视阈下应对抑郁症与骨质疏松症的运动调节机制研究进展 [J]. 中国体育科技, 2023, 59(1): 51-59. |
| [3] | 王培霞, 张勤, 周石仙, 等. 骨质疏松症营养干预研究进展 [J]. 中国骨质疏松杂志, 2023, 29(3): 409-412, 443. |
| [4] | 吴芷若, 霍亚南, 甘萍, 等. 抗骨质疏松症药物序贯治疗研究现状 [J]. 中国骨质疏松杂志, 2023, 29(1): 134-138. |
| [5] | 温永发, 邓伟民, 吕敦庆, 等. 高血压与骨质疏松症药物治疗间相关性的研究进展 [J]. 中国骨质疏松杂志, 2023, 29(4): 599-605. |
| [6] | 赵波, 许丙义, 徐海斌, 等. 老年2型糖尿病患者血清CYR61、caveolin-1水平与骨质疏松症的关系 [J]. 广东医学, 2023, 44(2): 224-228. |
| [7] | 胡贤飞, 李敏, 梁博程, 等. 早期干预对偏瘫患者继发骨质疏松症的防治 [J]. 中国骨质疏松杂志, 2023, 29(7): 1002-1006. |
| [8] | 焦楷磊, 张宏光, 夏维波, 等. 全国中老年骨质疏松症分级健康管理平台的设计与应用 [J]. 中国骨质疏松杂志, 2023, 29(7): 971-975. |
| [9] | 李树栋, 梁学振, 李刚. 生物信息学与机器学习识别诊断绝经后骨质疏松症患者的生物标志物 [J]. 中国骨质疏松杂志, 2023, 29(9): 1310-1314. |
| [10] | 李小云, 林青, 王昊宇, 等. 骨髓间充质干细胞衰老与骨质疏松症的研究进展 [J]. 中国病理生理杂志, 2023, 39(10): 1898-1903. |
| [11] | 常裕绅, 朱亮亮, 匡浩铭, 等. 金刚丸抗去卵巢大鼠骨质疏松症血清代谢组学研究 [J]. 中国骨质疏松杂志, 2023, 29(2): 179-185, 194. |
| [12] | 哈娜, 张新建, 海鑫. 中国绝经后骨质疏松症妇女不同抗骨质疏松治疗方案的经济学评价 [J]. 中国药物应用与监测, 2023, 20(3): 147-153. |
| [13] | 杜浩, 方志宇, 涂世成, 等. 个体化维生素D补充治疗绝经后妇女骨质疏松症的临床应用 [J]. 中国妇幼健康研究, 2024, 35(1): 92-95. |
| [14] | 聂梅. 戊酸雌二醇联合阿仑膦酸钠治疗绝经后妇女骨质疏松症患者的临床研究 [J]. 云南医药, 2021, 42(2): 171-173. |
| [15] | 张瑞娟, 宋涛. 妇女绝经后骨质疏松症患者应用阿仑膦酸钠联合阿法骨化醇治疗的效果 [J]. 甘肃科技, 2021, 37(23): 134-136. |
| [16] | 魏若愚, 张增建. 芪薯糖骨汤治疗绝经后妇女糖尿病合并骨质疏松症的临床观察 [J]. 糖尿病新世界, 2020, 23(7): 63-65. |
| [17] | 王琼, 李丽, 邵粟, 等. 基于常规药物的低频电疗联合超短波治疗绝经后妇女骨质疏松症的疗效 [J]. 分子影像学杂志, 2021, 44(2): 364-369. |
| [18] | 辛岩, 崔晓雯, 禹琦. 二甲双胍和西格列汀治疗对绝经后糖尿病合并骨质疏松症妇女骨密度和骨代谢的影响 [J]. 中国骨质疏松杂志, 2020, 26(10): 1486-1489, 1504. |
| [19] | 武慧琳. 不同给药方案阿仑膦酸钠治疗绝经后妇女骨质疏松症18个月效果 [J]. 养生保健指南, 2021(1): 88. |
| [20] | 周雯, 陈琳, 朱文彬. 联用补肾壮骨汤、阿仑膦酸钠治疗绝经后妇女骨质疏松症的疗效分析 [J]. 药物生物技术, 2021, 28(1): 38-41. |
| [21] | Hadji P, Boekhoff J, Hahn M, et al Pregnancy associated os teoporosis: a case control study [J]. Osteoporos Int, 2017, 28 (4): 1393-1399. |
| [22] | Bufscheidt S, Delsmann A, Rolvien T, el al MutatlonaI analvsis uncovers monogenic bone dlsorders in women with pregnan cy associated osteoporosis: ree novel mutations in rp5, co-|1a1, and co|1a2 [J]. Osteoporos lnf, 2018, 29(7): 1643-1651. |
| [23] | KyVernitakis, Reuter TC, Hellmeye r L, et al Subsequenf frac ture risk of wOmen with pregnancy and Iactation associated osteoporosis after a medIan of 6 years of foIjow up [J]. Oste oporos Int, 2018, 29(1): 135-142. |
| [24] | Polzonetti V, Pucciarelli S, Vincenzefti S, et al Dietarv intake of Vitamin d frOm dai ry prOducts reduces the risk Of Osteoporosis [J] Nutrents, 2020, 12(6): 1743. |
| [25] | Stumpf U, Kraus M, Hadii P lnfluence of denosumab on bone mineral density in a seVere case of pregnancy associated os teoporosis [J] Osteoporos Int, 2021, 32(1 1): 2383—2387. |
| [26] | 陈月芳, 尤共平, 罗华琼. 坤泰胶囊辅助治疗对绝经后骨质疏松症妇女骨密度、骨代谢和激素水平的影响 [J]. 中国骨质疏松杂志, 2020, 26(8): 1193-1196. |
| [27] | 张文龙. 地舒单抗及其联合双膦酸盐治疗绝经后女性骨质疏松症的疗效观察 [J]. 临床医药实践, 2023, 32(6): 431-434. |
| [28] | 李金庭, 孟祥悦, 刘洋, 等. 近10年针灸治疗女性绝经后骨质疏松症的临床与机制研究进展 [J]. 针灸临床杂志, 2023, 39(4): 106-111. |
| [29] | 冯逸豪, 李威, 黄振, 等. 从"虚瘀"理论探讨益气温经法改善淋巴循环治疗绝经后骨质疏松症 [J]. 中国骨质疏松杂志, 2024, 30(1): 104-107, 123. |
| [30] | 俞琪芳, 丁红生, 吴潍. 补肾膏方联合阿仑膦酸钠片治疗绝经妇女骨质疏松症肾精不足证临床研究 [J]. 新中医, 2020, 52(20): 91-94. |
| [31] | 赵萍, 徐丹, 赵靓, 等. 激素替代疗法联合阿仑膦酸钠治疗围绝经期妇女骨质疏松症的临床疗效分析 [J]. 特别健康, 2022(13): 286-287. |
| [32] | 李中锋, 邓强, 乔小万, 等. 绝经后骨质疏松症的中医脏腑认识及中药治疗概况 [J]. 中医临床研究, 2022, 14(10): 137-141. |
| [33] | 海伟丽. 阿伦膦酸钠与阿法骨化醇联合治疗妇女绝经后骨质疏松症的疗效 [J]. 中国医药指南, 2020, 18(4): 131. |
| [34] | 徐园园, 冯秀芝, 王静飞. 营养综合控制辅助治疗老年妇女骨质疏松症的效果 [J]. 中国妇幼保健, 2020, 35(22): 4162-4164. |
| [35] | 刘艺, 邓琳雯, 孙国娟. 左归丸预防围绝经期妇女骨质疏松症的有效性及安全性观察 [J]. 世界中西医结合杂志, 2022, 17(9): 1775-1779. |
| [36] | 李志文, 刘元禄, 杨永菊, 等. 补肾阳中药有效成分治疗骨质疏松症作用机制研究进展 [J]. 辽宁中医药大学学报, 2023, 25(10): 135-141. |
| [37] | 马遇春, 张林, 丛慧芳. 调枢壮骨方治疗绝经后骨质疏松症的临床观察 [J]. 中国中医药科技, 2023, 30(4): 751-754. |
| [38] | 王可可, 吴红群, 郭浩楠, 等. 金天格胶囊联合阿仑膦酸钠对围绝经期骨质疏松症妇女骨代谢生化指标及骨密度的影响分析 [J]. 贵州医药, 2022, 46(11): 1756-1757. |
| [39] | 陈兴剑, 宋赟. 阿仑膦酸钠联合抗骨增生胶囊治疗绝经后骨质疏松症临床研究 [J]. 实用中医药杂志, 2022, 38(4): 563-564. |
| [40] | 谭思敏, 陈文辉, 李双蕾, 等. 中医药治疗绝经后骨质疏松症的研究进展 [J]. 大众科技, 2022, 24(10): 71-74, 55. |
| [41] | 王文君. 妇女绝经后骨质疏松症分析与有效治疗方法研究 [J]. 健康之友, 2021(17): 77-78. |
| [42] | 吴平平, 董俊党, 王其静, 等. 阿伦磷酸钠联合鲑鱼降钙素与有氧运动对绝经后妇女骨质疏松症腰椎功能的影响 [J]. 临床合理用药杂志, 2022, 15(3): 40-43. |
| [43] | 杨晓婷, 张娟峰, 齐武强. 替勃龙联合阿仑膦酸钠对围绝经期及绝经后妇女骨质疏松症的疗效观察 [J]. 贵州医药, 2020, 44(1): 71-72. |
| [44] | 康照宁, 徐林轩, 蔡余力. 单味中药治疗骨质疏松症的机理研究 [J]. 中医临床研究, 2022, 14(8): 70-72. |
| [45] | 孙国平, 罗选翔, 潘彬. 绝经后骨质疏松症的预防和药物联合序贯治疗 [J]. 中国组织工程研究, 2020, 24(33): 5385-5390. |
| [46] | 陈芳, 张宜, 徐立, 等. 中西医治疗绝经后骨质疏松症的研究进展 [J]. 医药导报, 2021, 40(9): 1216-1220. |
| [47] | 史娜. 某医院体检藏汉妇女绝经后骨质疏松症危险因素分析 [D]. 河南: 郑州大学, 2021. |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us